Molecular Diagnostics
Predicting Cancer Relapse Improved by High-Throughput DNA Sequencing
Researchers have shown that high-throughput sequencing detects the earliest known signs of potential cancer relapse faster and in nearly twice the number of leukemia patients as flow cytometry, the current gold standard for detecting minimal residual disease. More...14 Jun 2012
Novel Microbe Biomarkers Reveal Evidence of Radiation Exposure
Researchers have identified unique biomarkers that could be used to confirm exposure to damaging radiation in large groups of individuals potentially exposed to unknown and variable doses for the purpose of triage and treatment. More...14 Jun 2012
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Gel Cards
DG Gel Cards
In Other News
Single Test Detects All Existing Strains of H5N1
Distinct Molecular Subtype of Prostate Cancer Discovered
Biomarkers Discovered for Prostate Cancer Detection and Recurrence
Biosignatures Distinguish Between Fatal Lung Diseases
Noninvasive Prenatal Test Launched
Plastic Chip Identifies DNA Sequences in Drop of Blood
Genetic Testing Service Introduced for Amyotrophic Lateral Sclerosis
Next Generation Digital PCR System Launched
Nonsurgical Test Developed For Brain Cancer
Molecular Methods Differentiate Breast Cancers
Urinary Test Score Unchanged by Chronic Prostatitis
Noninvasive Stool Test Biased by Patient's Age
Genetic Abnormality Discovered for Brain Cancer
Genomic Test Spares Cancer Patients Chemotherapy
Blood Test Inaugurated for Early Detection of Lung Cancer
Molecular Analysis Used to Identify Specific Cancers
Biomolecular System Launched for Proteins Quantitation
Genetic Mutation Discovered in Familial Chronic Diarrhea Syndrome
Biomarker Links Clinical Outcome of Lethal Tumor Metabolism
Leukemia Patients' Prognoses Predicted with Genetic Profiling
Rare Blood Types Due To Genetic Variation
Companion Diagnostic to Help Development of Cancer Therapy
Gene Variants Indicate Increased Susceptibility to Colon Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.